News

Clearly, some with schizophrenia fare better without antipsychotic drugs. But not all. Many individuals with schizophrenia are better off taking antipsychotic drugs for long-term.

Mood disorders in older adults are neither inevitable nor particularly resistant to treatment. With attention to the special needs of older patients during evaluation, treatment, and follow up, clinicians can help many patients derive greater enjoyment from their later years.

Psychiatrists experience the impact of managed care perhaps most acutely during the utilization review process, which has become a standard tool for the review of treatment modalities and levels of service in the managed care environment.

The authors emphasize the importance of risk and protective factors and risk prediction models; analyze the growing evidence base for preventive interventions; and describe the concept of mental health promotion.

The passing of poet and humanitarian Maya Angelou, a 50th high school reunion, Memorial Day, the Tomb of the Unknown Soldier, and a eulogy to the Unknown Psychiatrist. . .

With over 2 dozen FDA-approved antidepressants on the market, it is reasonable to ask: which antidepressants are most effective?

With regard to visual adverse effects in patients who take psychotropic medications, new is not always better or safer. More in this Brief Communication.

Treatment approaches to counter adverse metabolic effects associated with the atypicals.

What forces influence your decision to treat ADHD? Case vignettes and a back-to-basics approach may bring clarity to the diagnostic and therapeutic clinical processes that surround the decision.

I begin by remembering my hours as a patient and Freud’s “Fundamental Rule”: Say Whatever Comes to Mind...

Clinicians will be drawn in by author Charles R. Cross's personal experience documenting, Here We Are Now: The Lasting Impact of Kurt Cobain. Cobain, lead singer of Nirvana, committed suicide 20 years ago this month.

Take-home messages on the immunology of schizophrenia and NMDA receptor encephalitis from the Schizophrenia International Research Society conference here.

In the trenches of Alzheimer research, the battle continues . . . but where do we stand? Is the war on AD dementia nearing conclusion, or are we simply in the initial throes of the fight? Three experts weigh in.

How the Repressed-Recovered Memory–Multiple Personality Disorder iatrogenic epidemic-surely one of the most tragic chapters in the history of psychiatry, psychology, and psychotherapy-ended, and how psychotherapy patients came to be protected by informed consent.

A discussion of computerized cognitive training programs with the most independent supportive research that demonstrates a previously unrecognized degree of neuroplasticity, or cognitive flexibility, in the brain.

This video features a particularly poignant section of a Q&A between National Council for Behavioral Health President and CEO Linda Rosenberg and NatCon 2014 Keynote Speaker Hillary Rodham Clinton, on suicide.

What's your first impression of this Rorschach-type image? Is there a place for Rorschach measures in assessing psychotic functioning?

The topics in this Special Report provide a broad picture of the issues psychiatrists face as they take a clear-eyed look at the opportunities and challenges in the emerging health care system.

Although most major organizations recognize the importance of collaboration, the challenge for psychiatry is how to best integrate different aspects of psychiatric and primary care. Help here.

Psychiatrists are particularly susceptible to burnout because of the nature of their work and the populations they serve. Combat strategies here.

This article reviews the many forms of fee agreement and notes the important factors to consider as well as questions to ask to properly assess and vet what may be best for one’s practice.

Everything you need to know about the MOC process.

We talk about mental disorders as brain disorders, but what does that really mean? How does it change the way we think about autism, schizophrenia, depression, bipolar, and other illnesses? The answer to these questions are still evolving. More in this video exclusive with NIMH Director Thomas Insel, MD.

Vice President of the United States Joe Biden spoke at this year's American Psychiatric Association Annual Meeting in New York. Here, a video clip from his speech.

We do not have to set time aside to do something that helps validate our experience, while simultaneously coping with it. The lesson expressed in this psychiatry resident's poem.

Psychiatrists may find themselves embroiled in matters that extend beyond the routine doctor-patient relationship unless they are clear about the differences between their treatment and forensic roles.

Select natural products have been evaluated as adjunctive agents that may be combined with conventional antipsychotics, with promising preliminary findings. Music therapy, meditation, and mindfulness training may improve quality of life for individuals with schizophrenia. Details here.

I get a strong and encouraging response whenever I write or talk about saving normals from excessive treatment. I get almost no response when I write or talk about the shameful and wasteful neglect of the severely ill. We mistreat them barbarously and almost no one seems to care.

What expanded roles should psychiatrists be playing in the provision of proper pain management without taking their eyes off the issue of prescription opioid misuse and abuse? Insights here.

What factors are involved in parents’ decision to begin medication treatment for a child with ADHD? An overview of studies that provide clinically relevant information related to the course and treatment outcomes of ADHD in children and adolescents.